HIT Consultant
JUNE 10, 2022
In April, FDA Commissioner Dr. Robert Califf laid out areas of challenge and opportunity when it comes to improving health outcomes, restoring public trust in science, and making the most of our ongoing investments in data analytics and clinical research. Wang, Chief Medical Officer of COTA, Inc.
HIT Consultant
NOVEMBER 24, 2022
First, let’s examine the new regulatory framework the FDA established. Health plans offering the OTC benefit can also leverage the opportunity to educate members about the significant role hearing aids can play in improving their overall health. – What new opportunities will arise? Introducing OTC hearing aids.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
C&M Health Law
NOVEMBER 3, 2022
Food and Drug Administration (FDA) released a draft guidance that, if finalized, will update the agency’s 2018 guidance on its Breakthrough Devices Program (the “Program”). If this latest draft guidance is finalized after a period of public comment, the agency will incorporate the proposed language into the 2018 guidance.
Healthcare Law Today
FEBRUARY 1, 2022
It also requires that the Secretary report to Congress on the state of the SNS, and to issue guidance and hold annual meetings with public health officials and stakeholders on how states, territories, and Tribes can access the SNS. Modernizes public health data through biosurveillance and infectious disease data collection.
HIT Consultant
APRIL 1, 2024
Among its efforts is a focus on promoting community-level health behaviors, such as increasing screening efforts; reinforcing the benefit of prescription and over-the-counter medications; and targeting communities that are at elevated risk for heart disease due to social and economic conditions.
Bill of Health
FEBRUARY 27, 2024
By excluding diverse contributions to the psychedelic field, we risk establishing psychedelic practices that exacerbate racial health inequities (disparities) in which people of color experience worse health outcomes as compared to whites on a population level.
Healthcare IT Today
OCTOBER 1, 2022
Optellum is the leader in AI-enabled lung cancer diagnosis , and the first and only medtech company to attain FDA clearance, CE-MDR in the EU, and UKCA in the UK for its software platform Virtual Nodule Clinic. This disparity highlights a critical need for diagnosis and treatment at the earliest stage possible.
Expert insights. Personalized for you.
98 
Let's personalize your content